AQN vs NWE

The deterministic health scores indicate significant concerns, with a Piotroski F-Score of 4/9 signaling borderline financial stability and no available Altman Z-Score limiting distress risk assessment. Despite a recent 1Y price surge of +47.5%, the stock trades at a steep valuation (P/E 91.14 vs sector avg 19.73) while reporting a negative profit margin (-1.11%) and an unsustainable dividend payout ratio (371.43%). However, strong operating metrics like 25.07% operating margin, improving EPS trends (+12.5% YoY), and a 4.06% dividend yield provide some support. The lack of insider activity and mixed analyst sentiment (hold) further justify a cautious stance.

NWE exhibits a stable but mediocre Piotroski F-Score of 4/9, while trading at a significant premium to its Graham Number ($55.75) and Intrinsic Value ($20.58). Despite strong 1-year price appreciation, the fundamental outlook is clouded by a severe YoY earnings collapse of -44.80% and a dangerously high dividend payout ratio of 89.80%. Liquidity is a primary concern with a Quick Ratio of 0.31, suggesting potential short-term cash flow pressure. The combination of a bearish technical trend (10/100) and a current price well above analyst targets ($65.42) indicates a high risk of correction.